30
Participants
Start Date
November 15, 2024
Primary Completion Date
September 30, 2025
Study Completion Date
September 30, 2025
Carvedilol and alverine
On the basis of maintaining unchanged routine hepatoprotective and symptomatic supportive treatments and the original dose of carvedilol, participants will be administered with compound alverine citrate capsules (Le Jian Su; specification: each capsule contains alverine citrate 60 mg and simeticone 300 mg; manufactured by Laboratoires MAYOLY SPINDLER), at a dosage of 180 mg/day (1 capsule orally, 3 times a day), for a continuous period of 24 weeks.
Shanghai East Hospital
OTHER
Army Medical Center of PLA
OTHER_GOV
Shanghai Changzheng Hospital
OTHER